Search company, investor...
Search
Folia Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

foliahealth.com

Founded Year

2016

Stage

Unattributed | Alive

Total Raised

$7.16M

Last Raised

$6M | 1 yr ago

Mosaic Score

+40 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Folia Health

Folia Health is building a mobile application to help family caregivers notice changes in patients' health at home every day.

Folia Health Headquarters Location

78 Kirkland Street Unit 1

Cambridge, Massachusetts, 02138,

United States

617-306-1282

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Folia Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Folia Health is included in 2 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Folia Health News

Folia Health Technology Platform Used in First-of-its-Kind Real World Evidence Study for Sickle Cell Disease

Sep 15, 2022

Boston, Massachusetts, UNITED STATES BOSTON, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Today, Folia Health announced the initiation of the ASCEND Study, a first-of-its-kind, at-home observational real-world evidence study in which people living with sickle cell disease (SCD) will use Folia’s innovative technology platform to track their individual changes in symptoms and treatment use. The ASCEND Study, which is currently enrolling patients, is being conducted by Folia Health with funding from Global Blood Therapeutics, Inc. (GBT). The study will use Folia’s app and proprietary analytics methodology to measure outcomes in SCD with the aim of uncovering insights about the real-world experiences of individuals living with the condition, including the use of Oxbryta® (voxelotor), GBT’s first-in-class, once-daily oral therapy for the treatment of SCD. ASCEND will capture and measure Home Reported Outcomes (HROs), enabling individuals with SCD, as well as their caregivers, to leverage their own observations and lived experience to better understand the impact of treatment and health events. No additional clinic visits will be required for patients participating in this study as all data collection will be conducted remotely. “There is a significant need for more granular, patient-driven, high-quality data to understand the experience of individuals living with sickle cell disease and the impact of novel therapies like Oxbryta,” said Nell Meosky Luo, CEO and Founder of Folia Health. “In order for advancements in sickle cell disease to be better understood, we need to capture home-reported evidence that closes the gap between data from traditional endpoints collected in clinical trials and the real-world patient’s day-to-day experience. The ASCEND study will utilize the Folia mobile app or desktop platform to capture this evidence directly from patients in real time. We are thrilled to be working with GBT on such an exciting endeavor to better understand and measure the outcomes that matter to people living with SCD.” SCD is a rare blood disorder that affects millions worldwide; in the United States, approximately 100,000 people have the disease.1 It is most prevalent among those of sub-Saharan African descent, and is also more likely to affect people of Hispanic, Middle Eastern, South Asian, and Southern European ancestry.1 SCD causes the production of “sickled” or abnormal hemoglobin, a protein carried by red blood cells that carries oxygen to the body.2 This abnormality in hemoglobin results in the formation of the characteristic sickle shape of red blood cells in its deoxygenated form, thus giving the disease its name.3 Unlike normal healthy red blood cells, the sickle shaped cells are sticky, rigid and, due to their characteristic shape, get stuck in blood vessels, blocking blood flow to organs and causing infections and enormous pain.2 Complications resulting from a sickle cell crisis, including stroke, acute chest syndrome, organ damage, other hip and joint complications, can be life-threatening and in some cases cause premature death.4 "GBT supports efforts to better comprehend and assess the experiences of patients with sickle cell disease,” said Alain Romero, PharmD, Ph.D., Senior Vice President and Head of Global Medical Affairs at GBT. “We hope that using the Folia Health platform in the ASCEND Study will deliver new insights by enabling sickle cell disease patients to track their experiences and participate in meaningful research from their home.” Eligible participants include individuals age 13 and older who have been clinically diagnosed with SCD, and caregivers of children age 4 and older with SCD. To learn more about virtual study participation and to sign up, visit www.foliahealth.com/ascend . About Folia Health Folia is a patient-driven Health-IOS (Individual Operating System) that enables individuals to easily take an active role in their care, while contributing to precision diagnostics, patient-centered drug development, & better care for complex diseases. Folia’s rich longitudinal data and proprietary analytic methods provide a vital and missing piece in the emergence of a home-centered, data-driven healthcare ecosystem. Discover how to harness the power of patient and caregiver knowledge at www.foliahealth.com . References

Folia Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Folia Health Rank

  • When was Folia Health founded?

    Folia Health was founded in 2016.

  • Where is Folia Health's headquarters?

    Folia Health's headquarters is located at 78 Kirkland Street, Cambridge.

  • What is Folia Health's latest funding round?

    Folia Health's latest funding round is Unattributed.

  • How much did Folia Health raise?

    Folia Health raised a total of $7.16M.

  • Who are the investors of Folia Health?

    Investors of Folia Health include Social Starts and MassChallenge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.